PatchSiren

PatchSiren cyber security CVE debrief

CVE-2026-93936 ThemeREX Group CVE debrief

A critical vulnerability was found in the WordPress IPharm theme, versions up to and including 1.2.4. This issue allows for PHP Object Injection due to deserialization of untrusted data. The vulnerability has a CVSS score of 9.8, indicating a high severity level. Defenders should assess exposure and prioritize mitigation, including patching or updating the theme, implementing measures to prevent deserialization of untrusted data, and monitoring for suspicious activity. The vulnerability could lead to significant impacts if exploited, including code execution and data breaches. It is essential to verify patch deployment priority and review compensating controls for exposed systems.

Vendor
ThemeREX Group
Product
IPharm
CVSS
CRITICAL 9.8
CISA KEV
Not listed in stored evidence
Original CVE published
2026-10-10
Original CVE updated
2026-10-10
Advisory published
2026-10-10
Advisory updated
2026-10-10

Who should care

Defenders responsible for WordPress installations using the IPharm theme should assess exposure and prioritize mitigation. This includes administrators, security teams, and developers who manage or maintain WordPress sites with this theme installed.

Why it matters

CVE-2026-93936 is a critical PHP Object Injection vulnerability in the WordPress IPharm theme. Defenders should care because it could lead to significant impacts if exploited, including code execution and data breaches. Priority should be given to patching or mitigating this vulnerability.

  • Potential code execution if exploited.
  • Possible data breaches due to injection vulnerability.
  • Compromise of WordPress site integrity.
  • Verification of patch deployment priority.

Technical summary

The IPharm theme for WordPress, versions up to and including 1.2.4, is vulnerable to PHP Object Injection. This is due to the deserialization of untrusted data. An attacker could potentially exploit this to execute arbitrary code or achieve other malicious goals.

Defensive priority

Defenders should prioritize patching or mitigating this vulnerability as it could lead to significant impacts on confidentiality, integrity, and availability if exploited.

Recommended defensive actions

  • Patch or update the IPharm theme to a version beyond 1.2.4.
  • Implement measures to prevent deserialization of untrusted data.
  • Monitor for suspicious activity related to the IPharm theme.

Evidence notes

The vulnerability is described in the CVE record and the source item from cve_program_cvelist_v5. The information provided indicates a high severity vulnerability but does not specify exploitation or impact details.

Sources and references

Verified primary and authoritative sources

  • CVE-2026-93936 CVE Program record

    Publisher, destination, and source semantics verified

    URL: https://www.cve.org/CVERecord?id=CVE-2026-93936

    CVE Program - Official CVE Program record with source-provided CVE metadata.

  • CVE-2026-93936 NVD vulnerability detail

    Publisher, destination, and source semantics verified

    URL: https://nvd.nist.gov/vuln/detail/CVE-2026-93936

    NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.

Supplemental references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.